226 related articles for article (PubMed ID: 30146695)
1. Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
Hurria A; Soto-Perez-de-Celis E; Allred JB; Cohen HJ; Arsenyan A; Ballman K; Le-Rademacher J; Jatoi A; Filo J; Mandelblatt J; Lafky JM; Kimmick G; Klepin HD; Freedman RA; Burstein H; Gralow J; Wolff AC; Magrinat G; Barginear M; Muss H
J Am Geriatr Soc; 2019 May; 67(5):920-927. PubMed ID: 30146695
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
3. Functional decline and resilience in older adults over the age of 70 receiving radiotherapy for breast cancer: A pilot study.
Akkila S; Mahal S; Dawdy K; Cao X; Szumacher E
J Geriatr Oncol; 2023 Apr; 14(3):101476. PubMed ID: 36989937
[TBL] [Abstract][Full Text] [Related]
4. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
5. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
Gajra A; McCall L; Muss HB; Cohen HJ; Jatoi A; Ballman KV; Partridge AH; Sutton L; Parker BA; Magrinat G; Klepin HD; Lafky JM; Hurria A
J Geriatr Oncol; 2018 May; 9(3):221-227. PubMed ID: 29602735
[TBL] [Abstract][Full Text] [Related]
6. Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer.
Watters JM; Yau JC; O'Rourke K; Tomiak E; Gertler SZ
Ann Oncol; 2003 Dec; 14(12):1744-50. PubMed ID: 14630679
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
Klepin HD; Pitcher BN; Ballman KV; Kornblith AB; Hurria A; Winer EP; Hudis C; Cohen HJ; Muss HB; Kimmick GG
J Oncol Pract; 2014 Sep; 10(5):e285-92. PubMed ID: 25074878
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
Freedman RA; Pitcher B; Keating NL; Ballman KV; Mandelblatt J; Kornblith AB; Kimmick GG; Hurria A; Winer EP; Hudis CA; Cohen HJ; Muss HB;
Breast Cancer Res Treat; 2013 Jun; 139(2):607-16. PubMed ID: 23681403
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
10. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
[TBL] [Abstract][Full Text] [Related]
11. A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.
Mandelblatt JS; Makgoeng SB; Luta G; Hurria A; Kimmick G; Isaacs C; Tallarico M; Barry WT; Pitcher B; Winer EP; Hudis C; Cohen HJ; Muss HB
J Geriatr Oncol; 2013 Oct; 4(4):353-61. PubMed ID: 24472479
[TBL] [Abstract][Full Text] [Related]
12. Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.
Derks MG; de Glas NA; Bastiaannet E; de Craen AJ; Portielje JE; van de Velde CJ; van Leeuwen FE; Liefers GJ
Oncologist; 2016 Aug; 21(8):946-53. PubMed ID: 27368882
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC
J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595
[TBL] [Abstract][Full Text] [Related]
14. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
15. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
Ji J; Sun CL; Cohen HJ; Synold T; Muss H; Sedrak MS
J Clin Oncol; 2023 Jan; 41(2):307-315. PubMed ID: 36126235
[TBL] [Abstract][Full Text] [Related]
17. Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer.
Mortimer JE; Waliany S; Dieli-Conwright CM; Patel SK; Hurria A; Chao J; Tiep B; Behrendt CE
Cancer; 2017 May; 123(10):1810-1816. PubMed ID: 28061004
[TBL] [Abstract][Full Text] [Related]
18. [Influence of clinical and biographical factors on the quality of life of women with breast cancer receiving adjuvant chemotherapy].
Baena-Cañada JM; Estalella-Mendoza S; González-Guerrero M; Expósito-Álvarez I; Rosado-Varela P; Benítez-Rodríguez E
Rev Calid Asist; 2011; 26(5):299-305. PubMed ID: 21925913
[TBL] [Abstract][Full Text] [Related]
19. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer.
Mariano C; Lund JL; Peacock Hinton S; Htoo P; Muss H; Reeder-Hayes KE
J Geriatr Oncol; 2017 Jul; 8(4):242-248. PubMed ID: 28601373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
